122 related articles for article (PubMed ID: 11202092)
1. A pilot study of postoperative CHART and CHARTWEL in head and neck cancer.
Shah N; Saunders MI; Dische S
Clin Oncol (R Coll Radiol); 2000; 12(6):392-6. PubMed ID: 11202092
[TBL] [Abstract][Full Text] [Related]
2. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
[TBL] [Abstract][Full Text] [Related]
3. Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer.
Saunders MI; Rojas A; Lyn BE; Pigott K; Powell M; Goodchild K; Hoskin PJ; Phillips H; Verma N
Br J Cancer; 1998 Nov; 78(10):1323-8. PubMed ID: 9823973
[TBL] [Abstract][Full Text] [Related]
4. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck.
Trotti A; Klotch D; Endicott J; Ridley M; Greenberg H
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):13-21. PubMed ID: 8482619
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome and patterns of recurrence of head and neck squamous cell carcinoma with a limited field of postoperative radiotherapy.
Goto Y; Kodaira T; Furutani K; Tachibana H; Tomita N; Ito J; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hasegawa Y
Jpn J Clin Oncol; 2013 Jul; 43(7):719-25. PubMed ID: 23667153
[TBL] [Abstract][Full Text] [Related]
7. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
[TBL] [Abstract][Full Text] [Related]
8. Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial.
Trotti A; Klotch D; Endicott J; Ridley M; Cantor A
Head Neck; 1998 Mar; 20(2):119-23. PubMed ID: 9484942
[TBL] [Abstract][Full Text] [Related]
9. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
Dobrowsky W; Naudé J
Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
[TBL] [Abstract][Full Text] [Related]
10. [Prospective study of accelerated postoperative radiation therapy in patients with squamous-cell carcinoma of the head and neck].
Zouhair A; Coucke PA; Azria D; Pache P; Stupp R; Moeckli R; Mirimanoff RO; Ozsahin M
Cancer Radiother; 2003 Aug; 7(4):231-6. PubMed ID: 12914856
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
12. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
[TBL] [Abstract][Full Text] [Related]
13. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
[TBL] [Abstract][Full Text] [Related]
14. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.
Huang DT; Johnson CR; Schmidt-Ullrich R; Grimes M
Int J Radiat Oncol Biol Phys; 1992; 23(4):737-42. PubMed ID: 1618666
[TBL] [Abstract][Full Text] [Related]
16. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.
Dische S; Saunders M; Barrett A; Harvey A; Gibson D; Parmar M
Radiother Oncol; 1997 Aug; 44(2):123-36. PubMed ID: 9288840
[TBL] [Abstract][Full Text] [Related]
17. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
[TBL] [Abstract][Full Text] [Related]
18. Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas.
Muriel VP; Tejada MR; de Dios Luna del Castillo J
Radiother Oncol; 2001 Aug; 60(2):137-45. PubMed ID: 11439208
[TBL] [Abstract][Full Text] [Related]
19. CHART revisited: a conservative approach for advanced head and neck cancer.
Saunders M; Rojas AM; Dische S
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):127-33. PubMed ID: 18065214
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
